Jeanine O'Kane and Marie Emms, senior executives at Syneos Health, address rare disease pricing and the ties between manufacturers, payers and patient advocacy groups. Read the full article sponsored by Syneos Health on Scrip 100 website.
Jeanine O'Kane and Marie Emms, senior executives at Syneos Health, address rare disease pricing and the ties between manufacturers, payers and patient advocacy groups. Read the full article sponsored by Syneos Health on Scrip 100 website.
Already have a RSS feed reader?
